private digital health companies obesity management glp-1 research2guidance The GLP-1 Access Gap: Mapping

4 Restless Leg Syndrome (RLS) A neurological disorder known as restless leg syndrome, or RLS, causes uncomfortable feelings in the legs that are frequently characterized as tingling, hurting, or crawling. These sensations create an irresistible urge to move, especially during periods of rest or inactivity, such as bedtime

Unlike some weight loss interventions that produce permanent metabolic changes, GLP-1 drugs address the underlying appetite signaling mechanisms that drive weight gain

This enhanced stability is particularly crucial for ophthalmic applications, where the compound must survive the journey through the cornea, remain active in the aqueous humor, and eventually release carnosine directly into the lens tissue where it exerts its antioxidant effects

Long-Lasting Delivery